Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Working Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.351.592.521.691.66

What is the latest Working Capital/Sales ratio of CONCORD BIOTECH ?

The latest Working Capital/Sales ratio of CONCORD BIOTECH is 1.35 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.35
Mar20231.59
Mar20222.52
Mar20211.69
Mar20201.66

How is Working Capital/Sales of CONCORD BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2024 1.35
-15.09
Mar2023 1.59
-36.90
Mar2022 2.52
49.11
Mar2021 1.69
1.81
Mar2020 1.66 -

Other Financial Ratios of CONCORD BIOTECH


Compare Working Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹24,499.9 Cr 9.4% 3.9% 59.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹163,010.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

9.4%

3.9%

59.1%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses